Skip to main content
. 2024 Feb 19;13(3):609–617. doi: 10.1007/s40121-024-00935-0
Our analysis of reported real-world cases underscores the detrimental impact of drug–drug interactions (DDIs) between antiretrovirals (ARVs) and over-the-counter medications.
It emphasizes the critical necessity for comprehensive medication reconciliation, including non-prescription drugs.
It highlights the continued clinical significance of relevant DDIs associated with boosted ARV.
It highlights the importance of reporting real-world cases of DDIs.